Shoker Investment Counsel Inc. Sells 547 Shares of The Procter & Gamble Company (NYSE:PG)

Shoker Investment Counsel Inc. decreased its position in The Procter & Gamble Company (NYSE:PGFree Report) by 0.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 87,313 shares of the company’s stock after selling 547 shares during the quarter. Procter & Gamble accounts for about 5.1% of Shoker Investment Counsel Inc.’s investment portfolio, making the stock its 4th largest holding. Shoker Investment Counsel Inc.’s holdings in Procter & Gamble were worth $15,123,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble in the second quarter valued at about $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $29,000. POM Investment Strategies LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $34,000. Quest Partners LLC acquired a new stake in shares of Procter & Gamble during the second quarter worth approximately $36,000. Finally, Fairfield Financial Advisors LTD acquired a new stake in Procter & Gamble in the second quarter valued at $44,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In related news, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at $44,508,763.93. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 313,597 shares of company stock valued at $53,268,499. Company insiders own 0.18% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on PG shares. JPMorgan Chase & Co. raised their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Evercore ISI lifted their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Morgan Stanley increased their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Finally, TD Cowen initiated coverage on Procter & Gamble in a report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target for the company. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Get Our Latest Research Report on Procter & Gamble

Procter & Gamble Trading Up 2.6 %

Procter & Gamble stock opened at $167.73 on Friday. The firm has a 50-day moving average price of $171.08 and a two-hundred day moving average price of $168.15. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The firm has a market capitalization of $395.01 billion, a price-to-earnings ratio of 28.92, a PEG ratio of 3.48 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the firm earned $1.83 EPS. The firm’s revenue was down .6% compared to the same quarter last year. Sell-side analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.40%. Procter & Gamble’s dividend payout ratio is presently 69.31%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.